SIC 2833 – Medicinal Chemicals and Botanical Products
Valuation | |
---|---|
Market Cap ($M) | 616.51 |
Enterprise Value ($M) | 712.69 |
Book Value ($M) | 3,453.61 |
Book Value / Share | 3.68 |
Price / Book | 0.18 |
NCAV ($M) | -30.81 |
NCAV / Share | -0.03 |
Price / NCAV | -20.01 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.07 |
Return on Assets (ROA) | -0.06 |
Return on Equity (ROE) | -0.08 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.58 |
Current Ratio | 2.54 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 707.34 |
Assets | 4,191.75 |
Liabilities | 738.15 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
7,068,417 | 14,244,244 | 49.62 | |
9,047,766 | 17,062,329 | 53.03 | |
8,627,629 | 16,301,273 | 52.93 | |
25,620,178 | 47,155,101 | 54.33 | |
(click for more detail) |
Similar Companies | |
---|---|
TARS – Tarsus Pharmaceuticals, Inc. | TECH – Bio-Techne Corporation |
TERN – Terns Pharmaceuticals, Inc. | TNYA – Tenaya Therapeutics, Inc. |
TRML – Tourmaline Bio, Inc. |
Financial data and stock pages provided by
Fintel.io